Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30–35. The role of sRAGE biomarker as predictor of satisfactory outcomes

Abstract Background Patients with type 2 diabetes (T2D) and body mass index (BMI)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Surgery for obesity and related diseases 2016-08, Vol.12 (7), p.1337-1341
Hauptverfasser:	Horwitz, Daniel, M.S, Saunders, John K., M.D, Ude-Welcome, Aku, M.D, Marie Schmidt, Ann, M.D, Dunn, Van, M.D, Leon Pachter, H., M.D, Parikh, Manish, M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis of Variance Anti-Obesity Agents - therapeutic use Band Bariatric Surgery Biomarker Biomarkers - metabolism BMI under 35 Body Mass Index Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - therapy Female Follow-Up Studies Gastric bypass Gastroenterology and Hepatology Glycated Hemoglobin A - metabolism Humans Laparoscopy - methods Male Metabolic surgery Middle Aged Obesity Obesity - blood Obesity - therapy Receptor for Advanced Glycation End Products - metabolism Remission Induction Retrospective Studies Sleeve SRAGE Surgery Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Background Patients with type 2 diabetes (T2D) and body mass index (BMI)
ISSN:	1550-7289 1878-7533
DOI:	10.1016/j.soard.2016.01.016